Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (31-40 of 318) with videos related to

Pageof 32
Sort By:
Hepatitis Monthly|August 11, 2012
Treatment of patients with HCV related cirrhosis: many rewards with very few risksRoberta D'Ambrosio, Alessio Aghemo
Hepatic Medicine : Evidence and Research|May 14, 2014
Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectivesElisabetta Degasperi, Alessio Aghemo
Seminars in Immunopathology|September 27, 2012
Hepatocellular carcinoma in chronic hepatitis C: from bench to bedsideAlessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2014
Second wave anti-HCV protease inhibitors: too little too late?Stella De Nicola, Alessio Aghemo
Transplantation|June 13, 2024
Are We Ready to Discontinue Hepatitis B Immunoglobulins to Prevent Hepatitis B and D Recurrence in Liver Transplant Recipients?Stella De Nicola, Alessio Aghemo
Hepatology (Baltimore, Md.)|March 8, 2013
New horizons in hepatitis C antiviral therapy with direct-acting antiviralsAlessio Aghemo, Raffaele De Francesco
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
HCV screening: Moving from theory to practiceTommaso Lorenzo Parigi, Alessio Aghemo
Recenti Progressi in Medicina|August 30, 2016
[Chronic hepatitis C: standard of care and perspective]Alessio Aghemo, Stella De Nicola
Gastroenterology|December 3, 2014
Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the betterAlessio Aghemo, Maria Francesca Donato
Liver International : Official Journal of the International Association for the Study of the Liver|May 14, 2016
The quest for safe and effective treatments of chronic hepatitis C in patients with kidney impairmentStella De Nicola, Alessio Aghemo
Pageof 32

Showing results (31-40 of 318) with videos related to

Sort By:
Pageof 32
Hepatitis Monthly|August 11, 2012
Treatment of patients with HCV related cirrhosis: many rewards with very few risksRoberta D'Ambrosio, Alessio Aghemo
Hepatic Medicine : Evidence and Research|May 14, 2014
Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectivesElisabetta Degasperi, Alessio Aghemo
Seminars in Immunopathology|September 27, 2012
Hepatocellular carcinoma in chronic hepatitis C: from bench to bedsideAlessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2014
Second wave anti-HCV protease inhibitors: too little too late?Stella De Nicola, Alessio Aghemo
Transplantation|June 13, 2024
Are We Ready to Discontinue Hepatitis B Immunoglobulins to Prevent Hepatitis B and D Recurrence in Liver Transplant Recipients?Stella De Nicola, Alessio Aghemo
Hepatology (Baltimore, Md.)|March 8, 2013
New horizons in hepatitis C antiviral therapy with direct-acting antiviralsAlessio Aghemo, Raffaele De Francesco
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
HCV screening: Moving from theory to practiceTommaso Lorenzo Parigi, Alessio Aghemo
Recenti Progressi in Medicina|August 30, 2016
[Chronic hepatitis C: standard of care and perspective]Alessio Aghemo, Stella De Nicola
Gastroenterology|December 3, 2014
Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the betterAlessio Aghemo, Maria Francesca Donato
Liver International : Official Journal of the International Association for the Study of the Liver|May 14, 2016
The quest for safe and effective treatments of chronic hepatitis C in patients with kidney impairmentStella De Nicola, Alessio Aghemo
Pageof 32